# The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease

> **NCT01306955** · PHASE4 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 34 (estimated)

## Conditions studied

- Behcet's Disease

## Interventions

- **DRUG:** methylorednisolone
- **OTHER:** dextrose water 5%

## Key facts

- **NCT ID:** NCT01306955
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-08
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306955, "The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01306955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*